Answers are grounded in this paper and cite their sources.
This observational analysis reports prognostic significance of p120-catenin, COL4A2, and SOX10 in glioma, indicating their potential in treatment strategies.
p120-catenin is a potential tumor-promoting factor in glioma, and a prognostic marker in GBM. In contrast, COL4A2 and SOX10 appear to act as tumor suppressors in glioma pathophysiology. SOX10 may additionally be a valuable prognostic marker in female GBM patients.
No takes yet. Share an insight, caveat, or question.
Dumitru et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: